Back to results
US 2015/0148419 A1Published application
Metabolites of (1r-trans)-n-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]methyl]propanamide
AssigneeVanda Pharmaceuticals Inc.
InventorsMarlene Michelle Dressman, Deepak Phadke
Life of this patent
Estimating the term…
Abstract
Isolated metabolites of (1R-trans)-N-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]-methyl]propanamide, methods for their use, and compositions containing the metabolites.
Claims13
An isolated compound of formula II
- or a salt, stereoisomer, solvate, or hydrate thereof, in amorphous or crystalline form.
An isolated compound of formula III
- or a salt, stereoisomer, solvate, or hydrate thereof, in amorphous or crystalline form.
A pharmaceutical composition comprising:
- at least one compound selected from the group consisting of:
- a compound of Formula II, a compound of Formula III, and salts, stereoisomers, solvates, and hydrates thereof, in amorphous or crystalline form
- and
- and a pharmaceutically-acceptable carrier.
1 more element
7-10. (canceled)
Dependencies are inferred from the claim text.